Below, clinicians and researchers share insights on the neurological, behavioral, and emotional shifts they've observed and why many believe GLP-1s could play a meaningful role in addiction treatment and recovery support
Paratore S, Ciotti MT, Basille M, Vaudry D, Gentile A, Parenti R, Calissano P, Cavallaro S: Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival
Ideal Candidate For Semaglutide For Weight Loss Semaglutide is approved for adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related condition such as type 2 diabetes, hypertension, and dyslipidemia
Scale Our robust architectural and operational capacity allows us to support large-scale obesity and diabetes clinical trials across the globe, currently hosting over 600 active ePRO trials
This could be beneficial for people who need intensive or targeted glutathione therapy, such as those with specific medical conditions or treatment goals